Article info
PDFCommentary
Adult nursing
Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events
- Correspondence to Rachel Kennedy, Cardiology Department, University Hospital Limerick, Dooradoyle V94 F858, Ireland; rachel.staunton{at}gmail.com
Citation
Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events
Publication history
- Accepted November 17, 2019
- First published November 26, 2019.
Online issue publication
December 14, 2020
Article Versions
- Previous version (26 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.